Tronox (TROX) Chief Commercial Officer receives 42,900 share units grant

Rhea-AI Filing Summary

Tronox Holdings plc reported that its Chief Commercial Officer, Jeffrey A. Engle, acquired 42,900 shares of common stock on February 11, 2026 through a grant priced at $0 per share. After this award, he beneficially owns 189,826 shares in total, held directly.

The grant represents restricted share units that vest in three equal annual portions on March 5, 2027, March 5, 2028, and March 5, 2029. Each vesting date requires that the participant is still providing services to the company, tying the award to ongoing employment.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Engle Jeffrey A.

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	42,900	$0.00	--

Holdings After Transaction: Common Stock — 189,826 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Engle Jeffrey A.

(Last) (First) (Middle)

263 TRESSER BOULEVARD,

SUITE 1100

(Street)

STAMFORD CT 06901

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Tronox Holdings plc [ TROX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		42,900(1)	A	$0	189,826	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Share Units subject to this grant shall vest in equal annual portions on each of March 5, 2027, March 5, 2028 and March 5, 2029 (each, a "Vest Date") provided that the Participant is then providing services to the Company on each such Vest Date.

	/s/ Jeffrey Neuman, as attorney-in-fact	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Tronox (TROX) disclose for Jeffrey A. Engle?

Tronox disclosed that Chief Commercial Officer Jeffrey A. Engle received a grant of 42,900 shares of common stock at $0 per share. This award increased his directly held beneficial ownership to 189,826 shares following the reported transaction.

When did the reported Tronox (TROX) insider award take place?

The reported award to Tronox Chief Commercial Officer Jeffrey A. Engle took place on February 11, 2026. The Form 4 shows this as a grant-type acquisition of common stock, recorded with transaction code “A” for grant, award, or other acquisition.

How many Tronox (TROX) shares does Jeffrey A. Engle own after this transaction?

After the February 11, 2026 grant, Jeffrey A. Engle beneficially owns 189,826 Tronox common shares. The Form 4 indicates these shares are held directly, reflecting the addition of 42,900 shares from the reported award transaction.

What are the vesting terms of Jeffrey A. Engle’s Tronox restricted share units?

The restricted share units vest in three equal annual portions on March 5, 2027, March 5, 2028, and March 5, 2029. Vesting on each date requires that the participant is still providing services to Tronox at that specific vesting date.

Is Jeffrey A. Engle a director or officer of Tronox (TROX)?

Jeffrey A. Engle is reported as an officer of Tronox Holdings plc, serving as Chief Commercial Officer. The Form 4 identifies him in this executive role and does not mark him as a director or a 10% beneficial owner.

What transaction code was used for the Tronox (TROX) insider grant?

The transaction used code “A”, which indicates a grant, award, or other acquisition. This code shows the 42,900 Tronox common shares were received as an award, not purchased on the open market, and carried a stated price of $0 per share.